Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Progress in cell cycle research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 14593738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Covalent Inhibition of the Human 20S Proteasome with Homobelactosin C Inquired by QM/MM Studies

  2022cites this paper
• Compound Target Identification in Tissue-Specific Interaction Networks

  2021cites this paper
• A Practical Review of Proteasome Pharmacology

  2019cites this paper
• Design, Synthesis and Biological Evaluation of Cu(I) and Cu(II) Complexes with bis(pyrazolyl)acetates and related Bioconjugated Ligands

  2018cites this paper
• Bioactivity and Cytotoxic Effect of Cyanobacterial Toxin AgainstHepatocellular Carcinoma

  2017cites this paper
• DNA and protein binding, double-strand DNA cleavage and cytotoxicity of mixed ligand copper(II) complexes of the antibacterial drug nalidixic acid.

  2017cites this paper
• l-Tryptophan Schiff base cadmium(II) complexes as a new class of proteasome inhibitors and apoptosis inducers in human breast cancer cells

  2017cites this paper
• Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.

  2017cites this paper
• Potential Toxicity of Egyptian Ashwagandha: Significance for their Therapeutic Bioactivity and Anticancer Properties

  2015cites this paper
• Advances in copper complexes as anticancer agents.

  2014cites this paper
• Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models

  2013cites this paper
• Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes.

  2013cites this paper
• Inhibition of Mitogen-Activated Protein Kinase Erk1/2 Promotes Protein Degradation of ATP Binding Cassette Transporters A1 and G1 in CHO and HuH7 Cells

  2013cites this paper
• Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell

  2012cites this paper
• Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo

  2012cites this paper
• Effect of phaleria macrocarpa supplementation on apoptosis and tumor growth of C3H mice with breast cancer under treatment with adriamycin-cyclophosphamide.

  2011cites this paper
• Survivin (BIRC5) cell cycle computational network in human no‐tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation

  2011cites this paper
• Distinct proteomic profiles characterise non‐erosive from erosive reflux disease

  2011cites this paper
• Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.

  2010cites this paper
• Targeting tumor proteasome with traditional Chinese medicine.

  2010cites this paper
• Copper in diseases and treatments, and copper‐based anticancer strategies

  2009cites this paper
• Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo

  2009cites this paper
• Targeted therapy in acute myeloid leukaemia: current status and future directions

  2009cites this paper
• Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells

  2008cites this paper
• Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity.

  2008cites this paper
• Constructing a Virtual Proteasome

  2008cites this paper
• New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer

  2008cites this paper
• Disulfiram promotes the conversion of carcinogenic cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cells.

  2008cites this paper
• Relationship between the methylation status of dietary flavonoids and their growth‐inhibitory and apoptosis‐inducing activities in human cancer cells

  2008cites this paper
• Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells.

  2007cites this paper
• Methylation suppresses the proteasome‐inhibitory function of green tea polyphenols

  2007cites this paper
• A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.

  2007cites this paper
• Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts

  2007cites this paper
• Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulation

  2007cites this paper
• Proteomic characterization and identification of murine liver and small intestine proteins modulated by tea (Camellia sinensis) consumption

  2007cites this paper
• The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases.

  2006cites this paper
• Increased expression of genes that control ionic homeostasis, second messenger signaling and metabolism in the carotid plaques from patients with symptomatic stroke

  2006cites this paper
• Optimal Length Transportation Hypothesis to Model Proteasome Product Size Distribution

  2006cites this paper
• Carotid atherosclerotic plaques from symptomatic stroke patients share the molecular fingerprints to develop in a neoplastic fashion: a microarray analysis study.

  2005cites this paper
• Increased Expression of Valosin-Containing Protein (p97) Is Correlated With Disease Recurrence in Follicular Thyroid Cancer

  2005cites this paper
• Green Tea Polyphenols

  2005cites this paper
• Ufd1 exhibits the AAA-ATPase fold with two distinct ubiquitin interaction sites.

  2005cites this paper
• Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells

  2005cites this paper
• About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-α gene (ESR1) in breast cancer

  2004cites this paper
• Expression Level of Valosin-Containing Protein (p97) Is Correlated With Progression and Prognosis of Non-Small-Cell Lung Carcinoma

  2004cites this paper
• Elevated Expression of Valosin-Containing Protein (p97) Is Associated with Poor Prognosis of Prostate Cancer

  2004cites this paper
• Green tea and tea polyphenols in cancer prevention.

  2004influential citation
• Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.

  2004cites this paper
• About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer.

  2004cites this paper
• Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor.

  2004cites this paper
• Expression Level of Valosin-Containing Protein (p97) Is Associated with Prognosis of Esophageal Carcinoma

  2004cites this paper
• Copper storage diseases: Menkes, Wilsons, and cancer.

  2004cites this paper